NEOBIOSIS is a biotechnology company focused on the development and manufacturing of innovative perinatal products for research and clinical trials.

Our goal is simple: to help redefine the field of regenerative medicine through regenerative science and shape the future of this fledgling industry though meaningful partnerships and collaborations. We are uniquely positioned to help usher in this new era of medicine, which focuses on the potential of perinatal birth tissues including cells, EVs and matrix.

Disclaimer: Our Human Cell, EV and Tissue Products are not FDA approved or licensed for the prevention, treatment, diagnosis, mitigation and/or cure of any disease or condition, including COVID-19.